Navigation Links
3SBio Inc. Announces Unaudited Second Quarter Results
Date:8/17/2010

d other risk factors, uncertainties and assumptions that may affect 3SBio's business, financial conditions and results of operations, please refer to the Company's filings with the Securities and Exchange Commission at http://www.sec.gov , and, in particular, "Introduction - Cautionary Statement concerning Forward Looking Statements", Item 3.D "Risk Factors", Item 5. "Operating and Financial Review and Prospects", and other applicable discussions in 3SBio's annual report on Form 20-F for the year ended December 31, 2009.

All the statements in the Disclosures speak as of the date of the initial release, even if subsequently made available on the 3SBio website or otherwise. 3SBio undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, subsequent events or otherwise, after the date of this press release.

For more information, please contact: Investor Contacts Bo Tan Chief Financial Officer 3SBio Inc. Phone: +86-24-2581-1820 Email: ir@3SBio.com Tom Folinsbee Director of Investor Relations 3SBio Inc. Phone: +852-8191-6991 Email: ir@3SBio.com 3SBio Inc. Unaudited consolidated balance sheets (expressed in thousands) December 31, June 30, June 30, 2009 2010 2010 RMB RMB US$ (audited) (unaudited)(unaudited) Assets Current assets Cash and cash equivalents 262,767 145,637 21,476 Restricted cash 9,300 661 97 Time deposits with financial institutions 468,451 602,948 88,911 Notes receivable 31,265 38,259 5,642 Accounts receivable, less allowance for doubtful accounts: December 31, 2009 - RMB2,915; June 30, 2010 - RMB2,695 (US$397) 54,661 80,037 11,802 Inventories 15,406 17,820 2,628 Prepaid expenses and other receivables 8,705 16,029 2,364 Deferred tax assets 2,079 2,106 311 Total current assets 852,634 903,497 133,231 Available-for-sale securities 11,407 11,570 1,706 Long-term equity investment -- 1,874 276 Property, plant and equipmen
'/>"/>

SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. 3SBio Inc. Announces Second Quarter 2008 Results
2. 3SBio Inc. to Hold Annual General Meeting
3. 3SBio Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
4. 3SBio Inc. Announces Results of Annual General Meeting
5. 3SBio Inc. to Present at the UBS Global Life Sciences Conference
6. 3SBio Inc. Files for SFDA Approval of High-dose (36,000 IU) EPIAO
7. 3SBio Inc. Schedules 2008 Third Quarter Earnings Release on Monday, November 10, 2008
8. 3SBio Inc. Announces Preliminary Third Quarter 2008 Results
9. 3SBio Inc. Files for SFDA Approval of NuLeusin
10. 3SBio Inc. Announces Third Quarter 2008 Results
11. 3SBio Inc. to Present at the Piper Jaffray 20th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 2015  Peter Walter wurde als Gewinner ... seine bahnbrechende Arbeit ausgewählt, die sich damit ... sowie für die Entschlüsselung der Komponenten eines ... nutzen, der mit der Ansammlung von deformierten ... Biochemie an der University of California, San ...
(Date:3/27/2015)... 2015 Working in collaboration with the ... London , Richmond Pharmacology is the first centre ... study for an investigational RNAi therapeutic being developed for the ... nerves and heart. Read press release ... Based at St Georges University of London ...
(Date:3/26/2015)... WARREN, N.J., March 26, 2015  Roka Bioscience, ... company focused on providing advanced testing solutions for ... financial results for the three months and full ... Quarter 2014 Financial Results:Revenue for the quarter ended ... $689,000 for the fourth quarter of 2013 and ...
(Date:3/26/2015)... March 26, 2015  BioNano Genomics, Inc., the leader ... Salyer as chief commercial officer. Salyer has more ... sales teams in life sciences. At BioNano, Salyer will ... a genome-mapping platform to assemble a comprehensive view of ... To date, 32 institutions located in the ...
Breaking Biology Technology:Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 2Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 3Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 4Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 2Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 3Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 4Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 5Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 6Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 7BioNano Genomics Appoints Terry Salyer as Chief Commercial Officer 2BioNano Genomics Appoints Terry Salyer as Chief Commercial Officer 3
... , FREISING-WEIHENSTEPHAN, Germany, September 15 ... a collaboration agreement with,Allergan, Inc. (NYSE: AGN ... in drug delivery and ophthalmic drug,development with a goal ... , Under the terms of ...
... ... use an electric breast pump in public with her new patented device that allows a ... changer for breastfeeding mothers in the workplace, as anchorwoman attests, "It works!" , ... Sacramento, CA (PRWEB) September 15, 2009 -- ...
... , , BALTIMORE, Sept. 14 ... engaged in the development of advanced preclinical platforms and tumor specific ... financial results for the first quarter ended July 31, 2009. Full ... Form 10-Q at www.championsbiotechnology.com . , , ...
Cached Biology Technology:Pieris AG Enters into Anticalin Collaboration With Allergan, Inc. 2ER Doctor Demonstrates Breast Pump on Live TV with Patented New Freemie Hands-Free System 2ER Doctor Demonstrates Breast Pump on Live TV with Patented New Freemie Hands-Free System 3ER Doctor Demonstrates Breast Pump on Live TV with Patented New Freemie Hands-Free System 4Champions Biotechnology Reports Fiscal 2010 First Quarter Financial Results 2Champions Biotechnology Reports Fiscal 2010 First Quarter Financial Results 3Champions Biotechnology Reports Fiscal 2010 First Quarter Financial Results 4Champions Biotechnology Reports Fiscal 2010 First Quarter Financial Results 5
(Date:3/23/2015)... --NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... market, announces its biometric payment technology, the Wocket® smart wallet, ... March 30 th . The new ... York markets. Gino Pereira ... new ad campaign following the recent initial shipment of Wocket ...
(Date:3/20/2015)... Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) has announced the addition ... report to their offering. This report analyzes ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period 2013 ...
(Date:3/20/2015)... Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ) has announced the addition ... report to their offering. This report analyzes ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... . Annual estimates and forecasts are provided for ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5
... Prevention and Treatment of Cardiovascular Disease , ... the occasion, the Journal of the American Dietetic ... factors for treating and preventing cardiovascular disease. The ... and other articles provide scientific rationale for food ...
... worlds poorest regions could face severe crop losses in the ... new study by researchers at Stanford Universitys Program on Food ... published in the Feb. 1 issue of the journal Science. ... on agriculture for their livelihoods, said lead author David Lobell, ...
... blood vessels is by creating too much competition for an ... That amino acid, L-arginine, is broken down by the enzyme ... from the proteins we eat. Diabetics have a lot of ... says Dr. Maritza Romero, postdoctoral fellow at the Medical College ...
Cached Biology News:Highlights from the February 2008 Journal of the American Dietetic Association 2Highlights from the February 2008 Journal of the American Dietetic Association 3Impoverished areas of Africa and Asia face severe crop losses from climate change in 20 years 2Impoverished areas of Africa and Asia face severe crop losses from climate change in 20 years 3Impoverished areas of Africa and Asia face severe crop losses from climate change in 20 years 4Diabetes makes it hard for blood vessels to relax 2
... Monoclonal Antibody, Unconjugated Applications: ... ICC: Use at an assay dependent dilution. WB: ... ug/ml, this concentration is determined using a whole ... kDa. Not tested in other applications. Optimal ...
Monoclonal Anti-Gα o purified immunoglobulin buffered aqueous solution Solution in phosphate buffered saline pH 7.4, containing 0.08% sodium azide. partially purified bovine brain Gα O ...
SHP-2 Antibody...
Anti human PPAR gamma2 mouse monoclonal antibody...
Biology Products: